Gebbia V - Search Results

1

Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer: a phase II study of the Southern Italy Oncology Group (GOIM).

Gebbia V, Borsellino N, Testa A, Latteri MA, Milia V, Valdesi M, Giotta F, Gebbia N, Colucci G. Gebbia V, et al. Among authors: gebbia n. Anticancer Drugs. 1997 Nov;8(10):943-8. doi: 10.1097/00001813-199711000-00005. Anticancer Drugs. 1997. PMID: 9436637 Clinical Trial.

2

Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancer.

Gebbia V, Valenza R, Testa A, Zerillo G, Restivo S, Cupido G, Ingria F, Spadafora G, Barbaccia C, Cannata G, et al. Gebbia V, et al. Med Oncol Tumor Pharmacother. 1992;9(4):165-8. doi: 10.1007/BF02987751. Med Oncol Tumor Pharmacother. 1992. PMID: 1342059

3

Chemotherapy in head and neck cancer (I): Management of recurrent or metastatic disease.

Gebbia V, Zerillo G, Gebbia N, Agostara B, Callari A, Rausa L. Gebbia V, et al. Among authors: gebbia n. J Chemother. 1992 Aug;4(4):244-59. doi: 10.1080/1120009x.1992.11739173. J Chemother. 1992. PMID: 1403082 Review. No abstract available.

4

Hydroxyurea modulates 5-fluorouracil antineoplastic activity in advanced head and neck carcinoma pretreated with chemotherapy.

Gebbia V, Gebbia N, Russo A, Testa A, Valenza R, Zerillo G, Ingria F, Spadafora G, Rausa L. Gebbia V, et al. Among authors: gebbia n. Anticancer Drugs. 1992 Aug;3(4):347-9. doi: 10.1097/00001813-199208000-00005. Anticancer Drugs. 1992. PMID: 1421429

5

Cisplatinum in combination with 5-fluorouracil and citrovorum factor in the treatment of advanced colorectal carcinoma.

Palmeri S, Gebbia V, Russo A, Gebbia N, Rustum Y, Rausa L. Palmeri S, et al. Among authors: gebbia v, gebbia n. Cancer Invest. 1992;10(6):497-504. doi: 10.3109/07357909209024811. Cancer Invest. 1992. PMID: 1422888 Clinical Trial.

6

The effects of the macrocyclic lactone bryostatin-1 on leukemic cells in vitro.

Gebbia V, Citarrella P, Miserendino V, Valenza R, Borsellino N, Pesta A, Pettit R, May S. Gebbia V, et al. Tumori. 1992 Jun 30;78(3):167-71. doi: 10.1177/030089169207800304. Tumori. 1992. PMID: 1440938

7

High-dose folinic acid and 5-fluorouracil plus cisplatin on a weekly schedule in the treatment of advanced cancer of the head and neck.

Gebbia V, Russo A, Gebbia N, Rausa L, Ingria F, Spatafora G, Zerillo G, Cimino A, Pastorello T, Ferrara P, et al. Gebbia V, et al. Among authors: gebbia n. J Cancer Res Clin Oncol. 1992;118(6):458-62. doi: 10.1007/BF01629430. J Cancer Res Clin Oncol. 1992. PMID: 1618894

8

Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.

Rausa L, Russo A, Gebbia V, Gebbia N, D'Alessandro N, Palmeri S. Rausa L, et al. Among authors: gebbia v, gebbia n. J Cancer Res Clin Oncol. 1991;117(3):266-8. doi: 10.1007/BF01625437. J Cancer Res Clin Oncol. 1991. PMID: 1709643

9

Intracavitary beta-interferon for the management of pleural and/or abdominal effusions in patients with advanced cancer refractory to chemotherapy.

Gebbia V, Russo A, Gebbia N, Valenza R, Testa A, Palmeri S, Rausa L. Gebbia V, et al. Among authors: gebbia n. In Vivo. 1991 Nov-Dec;5(6):579-81. In Vivo. 1991. PMID: 1810442

10

A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma.

Palmeri S, Gebbia V, Russo A, Gebbia N, Rustum Y, Rausa L, Creaven P, Petrelli N. Palmeri S, et al. Among authors: gebbia v, gebbia n. J Chemother. 1991 Jun;3(3):170-5. doi: 10.1080/1120009x.1991.11739087. J Chemother. 1991. PMID: 1919654 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters